(Q81093833)

English

Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers

scientific article published on 01 November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

stem cell transplantation

1 reference

based on heuristic

inferred from title

Juan Carlos Hernandez-Boluda

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Maria José Terol

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Goterris R

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Teruel A

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Gómez C

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Lis MJ

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Tormo M

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Solano C

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Arbona C

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

847-853

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113660%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705147

0 references

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

The whys and hows of hematopoietic progenitor and stem cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yields

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitor cell collections for autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful autologous bone marrow rescue in patients who failed peripheral blood stem cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization and outcome of "hard to mobilize"' lymphoma patients undergoing autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

The CD34+90+ cell dose does not predict early engraftment of autologous blood stem cells as well as the total CD34+ cell dose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

A combination of low-dose cyclophosphamide and colony-stimulating factors is more cost-effective than granulocyte-colony-stimulating factors alone in mobilizing peripheral blood stem and progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

G-CSF alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma: results depend on degree of previous pretreatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705147

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81093833&oldid=2055615450"